1: Guet-Revillet H, Emirian A, Groh M, Nebbad-Lechani B, Weiss E, Join-Lambert O, Bille E, Jullien V, Zahar JR. Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli. Antimicrob Agents Chemother. 2014 Aug;58(8):4899-901. doi: 10.1128/AAC.02509-14. Epub 2014 Apr 28. PubMed PMID: 24777104; PubMed Central PMCID: PMC4135984.
2: Brunetti L, Kagan L, Forrester G, Aleksunes LM, Lin H, Buyske S, Nahass RG. Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy. Clin Ther. 2016 Jan 1;38(1):204-10. doi: 10.1016/j.clinthera.2015.11.009. Epub 2015 Dec 11. PubMed PMID: 26686826; PubMed Central PMCID: PMC4715936.